Trinity Capital, an international alternative asset manager, committed $20 million in growth capital to Emboline, a MedTech company focused on reducing strokes and other complications during interventional heart procedures.
“We’re proud to partner with the Emboline team as they advance their mission to reduce strokes and other complications associated with heart procedures,” Rob Lake, senior managing director at Trinity Capital, said. “The team’s passion and dedication to improving patient safety is inspiring, and we’re excited to support them as they expand access to the Emboline system.”
Scott Russell, president and CEO of Emboline, said, “We are entering an important phase as we prepare for the commercial introduction of the Emboliner system. Trinity Capital’s growth financing strengthens our ability to scale manufacturing, expand our team and support the clinical and regulatory milestones that will bring this technology to patients worldwide.”
This financing will support Emboline in preparing for the commercial launch of the Emboliner system while continuing to advance its platform of technologies aimed at reducing risk during minimally invasive heart procedures.
